Eastern Europe: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Eastern Europe

The East European prophylactic medicaments containing insulin market stood at $X in 2022, remaining constant against the previous year. The market value increased at an average annual rate of +1.2% from 2012 to 2022; however, the trend pattern remained relatively stable, with only minor fluctuations throughout the analyzed period. The level of consumption peaked at $X in 2015; however, from 2016 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Eastern Europe

In value terms, prophylactic medicaments containing insulin production expanded to $X in 2022 estimated in export price. Overall, production, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 when the production volume increased by 16% against the previous year. The level of production peaked at $X in 2015; however, from 2016 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Eastern Europe

Prophylactic medicaments containing insulin exports contracted modestly to X tons in 2022, which is down by -2% on 2021 figures. In general, exports, however, enjoyed resilient growth. The most prominent rate of growth was recorded in 2018 when exports increased by 35%. Over the period under review, the exports hit record highs at X tons in 2021, and then declined slightly in the following year.

In value terms, prophylactic medicaments containing insulin exports fell to $X in 2022. Total exports indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of +7.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by +13.2% against 2020 indices. The most prominent rate of growth was recorded in 2014 with an increase of 44%. The level of export peaked at $X in 2021, and then declined in the following year.

Exports by Country

Hungary represented the key exporter of medicaments containing insulin but not antibiotics in measured doses in Eastern Europe, with the volume of exports recording X tons, which was approx. 48% of total exports in 2022. Poland (X tons) ranks second in terms of the total exports with a 16% share, followed by Ukraine (13%), the Czech Republic (10%) and Russia (7%). Latvia (X tons) and Romania (X tons) held a little share of total exports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin exports from Hungary stood at +4.2%. At the same time, Russia (+104.2%), Latvia (+99.4%), Ukraine (+40.2%), Romania (+25.0%), the Czech Republic (+17.1%) and Poland (+6.9%) displayed positive paces of growth. Moreover, Russia emerged as the fastest-growing exporter exported in Eastern Europe, with a CAGR of +104.2% from 2012-2022. While the share of Ukraine (+12 p.p.), Russia (+7 p.p.), the Czech Republic (+5.6 p.p.), Latvia (+2.7 p.p.) and Romania (+1.5 p.p.) increased significantly in terms of the total exports from 2012-2022, the share of Poland (-2.5 p.p.) and Hungary (-23.7 p.p.) displayed negative dynamics.

In value terms, Hungary ($X) remains the largest prophylactic medicaments containing insulin supplier in Eastern Europe, comprising 47% of total exports. The second position in the ranking was taken by the Czech Republic ($X), with a 21% share of total exports. It was followed by Russia, with a 7.8% share.

In Hungary, prophylactic medicaments containing insulin exports expanded at an average annual rate of +4.3% over the period from 2012-2022. In the other countries, the average annual rates were as follows: the Czech Republic (+15.4% per year) and Russia (+85.4% per year).

Export Prices by Country

In 2022, the export price in Eastern Europe amounted to $X per ton, with a decrease of -10.8% against the previous year. Over the period under review, the export price recorded a slight reduction. The most prominent rate of growth was recorded in 2014 an increase of 14%. The level of export peaked at $X per ton in 2016; however, from 2017 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Romania ($X per ton), while Ukraine ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Latvia (+3.0%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Eastern Europe

Prophylactic medicaments containing insulin imports dropped to X tons in 2022, with a decrease of -8.3% on the previous year. The total import volume increased at an average annual rate of +3.5% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2013 with an increase of 23%. The volume of import peaked at X tons in 2021, and then shrank in the following year.

In value terms, prophylactic medicaments containing insulin imports declined rapidly to $X in 2022. Over the period under review, imports recorded a perceptible slump. The pace of growth appeared the most rapid in 2013 when imports increased by 8.2%. As a result, imports reached the peak of $X. From 2014 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2022, Hungary (X tons), distantly followed by Romania (X tons), Russia (X tons), the Czech Republic (X tons), Poland (X tons) and Ukraine (X tons) were the major importers of medicaments containing insulin but not antibiotics in measured doses, together mixing up 88% of total imports. Bulgaria (X tons) held a relatively small share of total imports.

From 2012 to 2022, the biggest increases were recorded for Romania (with a CAGR of +8.8%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Hungary ($X), Romania ($X) and the Czech Republic ($X) constituted the countries with the highest levels of imports in 2022, with a combined 56% share of total imports.

Romania, with a CAGR of +4.4%, recorded the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Eastern Europe stood at $X per ton in 2022, with a decrease of -8.8% against the previous year. Over the period under review, the import price continues to indicate a abrupt descent. The most prominent rate of growth was recorded in 2018 when the import price increased by 2.8% against the previous year. Over the period under review, import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Poland ($X per ton), while Russia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Bulgaria (-1.3%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :